CureVac doesn't rule out speedy approval process for its prospective COVID-19 vaccine

On August 16, German biotechlogy firm CureVac Chief Executive said it does t rule out a speedy approval process for its prospective vaccine against contagious coronavirus. According to media reports company expects to put its vaccine in market by mid-2021. Getting speedy approval shows company is pushing for an earlier release date. However, Chief Executive Officer Franz-Werner Haas did t give any details on how likely this was. Speaking to an online financial website Franz-Werner Haas said CureVac is t ruling out accelerated approval, but this can only be achieved in close cooperation with authorities.

Re: Germany: Health Minister Optimistic Of Having COVID-19 Vaccine In Coming Months

CureVac is backed by philanthropist, billionaire, and Microsoft founder Bill Gates, on August 14 it got listed on Nasdaq stock market and raised $ 213 million. outcome of recently started clinical trials of company’s perspective coronavirus vaccine will be published in autumn, Haas said. He also reiterated that at moment approval was expected in first half of next year.

company is researching how to use molecules carrying a specific genetic code called messenger RNA (mRNA) to treat a series of diseases, including COVID-19. By using messenger RNA, researchers hope y can compel a patient's own body to create proteins that can play an important role in fighting disease.

Re: Embattled Belarus President Calls For Russian Military Assistance, Says 'we Will Perish'

Germany is optimistic

Last week German Health Minister Jens Spahn said that he expects a registered COVID-19 vaccine in coming months and "definitely next year" as global vaccine race intensifies after Russian anuncement. Spahn’s forecast regarding vaccine echoed with a w-withdrawn report by Robert Koch Institute which predicted a vaccine by autumn. However, Spahn declined to anunce a specific month, saying re are several factors that need to be analyzed before making such a prediction. German minister said that re is it yet to be determined frequency of doses people would need to remain safe from infectious disease or how long immunity conferred by vaccine would last.

Re: New Zealand Director-General Of Health Reports 9 News Virus Cases

Re: New Zealand PM Jacinda Ardern Postpones national election Amid Renewed COVID-19 Concerns